NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Monday that revenues for its fiscal second quarter increased 6 percent year over year.

For the three months ended Mar. 31, Agilent recorded $ 1.02 billion in revenues compared to $963 million in Q2 2015, and beating the average Wall Street estimate of $983.3 million. Excluding currency effects, its recently divested NMR business, and any other acquisition and divestitures, core revenue growth was 8 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.